循環器ジャーナル69巻3号

2021年07月発行

特集 成人先天性心疾患 エキスパートコンセンサス Ⅲ．成人先天性心疾患の病態別の治療指針

心不全に対する薬物療法

著者： 坂本一郎¹

所属機関： ¹九州大学病院循環器内科

ページ範囲：P.451 - P.455

Point
・慢性心不全の薬物療法は，体心室収縮能が低下しているか否かで大きく異なる．
・Fontan手術後症例では他の心不全と違った視点での評価・治療が必要である．

参考文献

1) 日本循環器学会/日本心不全学会：急性・慢性心不全診療ガイドライン（2017年改訂版）．2018

2) CONSENSUS Trial Study Group:Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study（CONSENSUS）. N Engl J Med 316:1429-1435, 1987

3) Yusuf S, Pitt B, Davis CE, et al:Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 327:685-691, 1992

4) Packer M, Poole-Wilson PA, Armstrong PW, et al:Comparative effects of low and high doses of the angioten-sin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. Circulation 100:2312-2318, 1999

5) Swedberg K, Komajda M, Böhm M, et al:Ivabradine and outcomes in chronic heart failure（SHIFT）:a randomised placebo-controlled study. Lancet 376:875-885, 2010

6) McMurray JJ, Packer M, Desai AS, et al:Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 371:993-1004, 2014

7) Kosiborod MN, Jhund PS, Docherty KF, et al:Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction:Results From the DAPA-HF Trial. Circulation 141:90-99, 2020

8) Digitalis Investigation Group:The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 336:525-533, 1997

9) Zaragoza-Macias E, Zaidi AN, Dendukuri N, et al:Medical Therapy for Systemic Right Ventricles:A Systematic Review（Part 1）for the 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease:A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 139:e801-e813, 2019

10) Ohuchi H, Miyazaki A, Negishi J, et al:Hemodynamic determinants of mortality after Fontan operation. Am Heart J 189:9-18, 2017

11) Miike H, Ohuchi H, Hayama Y, et al:Systemic Artery Vasoconstrictor Therapy in Fontan Patients with High Cardiac Output-Heart Failure:A Single-Center Experience. Pediatr Cardiol 2021 Online ahead of print.